Diabetes Clinical Trials in Massachusetts

Showing 301-320 of 534 trials

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

NCT00451321

The purpose of this study is to optimize several multi-dose regimens of otelixizumab, determine the highest biologically active dose, evaluate biomarkers and surrogates of efficacy, and to evaluate the effects of each multi-dose regimen of otelixizumab against standard safety and efficacy parameters.

Diabetes Mellitus, Type 1

GlaxoSmithKline88 participantsStarted Jul 2006

Birmingham, Alabama, United States • Walnut Creek, California, United States • Aurora, Colorado, United States +14 more locations

COMPLETED24 miles

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

NCT03232437

A three site study to evaluate the reproducibility of the Aina HbA1c Monitoring System in quantitative determination of glycosylated hemoglobin (HbA1c) took place at the following sites: 1. Forsyth Institute in Cambridge, MA 2. Orange County Research Center in Tustin, CA 3. ActivMed Practices \& Research in Methuen, MA

Diabetes

Jana Care6 participantsStarted Jun 2017

Tustin, California, United States • Cambridge, Massachusetts, United States • Methuen, Massachusetts, United States

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

Diabetes Trials in Other Cities

Extended Follow-Up After Islet Transplantation in T1D

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

The Summer Camp Study 2: Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas

Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon

Physical Health in Midlife: Influences of Adversity and Relationships Over Time

UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation

Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

Effect of Dietary Fat on Glycemic Control in Type 1 Diabetes

Evaluation of Fats on Postprandial Glucose Control

Glycemic Index - Variability Among Individuals

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Thiazolidinedione Intervention With Vitamin D Evaluation

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

Other Conditions in Massachusetts